CME Educational Objectives 1. Understand the prevalence of co-occurring anxiety disorders and substance use disorders. 2. List the major diagnostic considerations in assessing co-occurring anxiety disorders among individuals with substance use disorders. 3. Demonstrate awareness of the pharmacologic and psychosocial treatments to date in this area.
No takes yet. Share an insight, caveat, or question.
Back et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: